Emergent BioSolutions EBS
NYSE EBS
$6.29 -0.07 (-1.10%)
As of: Oct 20, 2026 · 3:59 PM EDT

Emergent BioSolutions (EBS) Sales of Property, Plant and Equipment (2012 - 2026)

Updated

Emergent BioSolutions' Sales of Property, Plant and Equipment was $200,000 in Q2 2026, up 100.0% from $100,000 a year earlier.

Analysis

Emergent BioSolutions (EBS) Sales of Property, Plant and Equipment (2012 - 2026) Analysis & Trends

For FY2025, Sales of Property, Plant and Equipment at Emergent BioSolutions came in at $38.2 million, up 383.5% from FY2024.

  • In earlier years, Sales of Property, Plant and Equipment was $7.9 million in FY2024.
  • The Q2 2026 figure marks the highest quarterly Sales of Property, Plant and Equipment since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Sale) (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 63.00 Mn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 26.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 4.00 Mn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Emergent BioSolutions 325.34 Mn -425.56 Mn 137.20 Mn 200,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 200,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 38.10 Mn
Dec 31, 2024 300,000.00
Sep 30, 2024 7.60 Mn
Mar 31, 2012 11.77 Mn
API Access

Emergent BioSolutions Sales of Property, Plant and Equipment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sales-of-property-plant-and-equipment&ticker=EBS&period=max&api_key=YOUR_API_KEY